Only a few days to go: We’re raising £25,000 to keep TheyWorkForYou running and make sure people across the UK can hold their elected representatives to account.

Donate to our crowdfunder

NHS: Drugs

Department of Health written question – answered on 4th March 2016.

Alert me about debates like this

Photo of Andrew Gwynne Andrew Gwynne Shadow Minister (Health)

To ask the Secretary of State for Health, with reference to page 24 of the Accelerated Access Review, published in October 2015, what steps he is taking to ensure that drugs that target the genetically validated targets (a) PCSK9 and (b) BCL2 are introduced into routine NHS care; and if he will make a statement.

Photo of Ben Gummer Ben Gummer The Parliamentary Under-Secretary of State for Health

The Accelerated Access Review, chaired by Sir Hugh Taylor, will make recommendations to government on reforms to accelerate access for National Health Service patients to innovative medicines and medical technologies making our country the best place in the world to design, develop and deploy these products. The terms of the reference for the review focus on faster access to innovations, which may include drugs that target genetically validated targets such as PCSK9 and BCL2.

Does this answer the above question?

Yes0 people think so

No0 people think not

Would you like to ask a question like this yourself? Use our Freedom of Information site.